Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
19.00
-0.01 (-0.05%)
At close: Nov 20, 2024, 4:00 PM
17.99
-1.01 (-5.32%)
Pre-market: Nov 21, 2024, 4:41 AM EST
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $100.28 million as of November 21, 2024. Its market cap has increased by 1,651.44% in one year.
Market Cap
100.28M
Enterprise Value
94.26M
1-Year Change
1,651.44%
Ranking
Category
Stock Price
$19.00
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $100.28M, a decrease of -63.69%. That is a compound annual growth rate of -18.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 89.38M | 1,667.32% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | 70.09M | -59.48% |
| Dec 31, 2019 | 172.99M | -37.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assembly Biosciences | 99.95M |
| Anixa Biosciences | 99.76M |
| Quantum-Si incorporated | 95.92M |
| Karyopharm Therapeutics | 95.82M |
| FONAR | 95.41M |
| Immunic | 93.68M |
| Harvard Bioscience | 93.55M |
| PetMed Express | 93.27M |